1. Epstein JB, Thariat J, Bensadoun RJ, Barasch A, Murphy BA, Kolnick L, Popplewell L, Maghami E (2012) Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer JClin 62 (6):400-422. doi:10.3322/caac.21157 [doi]
2. Rosenthal DI, Lewin JS, Eisbruch A (2006) Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. JClinOncol 24 (17):2636-2643. doi:24/17/2636 [pii];10.1200/JCO.2006.06.0079 [doi]
3. van der Molen L, van Rossum MA, Burkhead LM, Smeele LE, Hilgers FJ (2009) Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review. EurArchOtorhinolaryngol 266 (6):889-900. doi:10.1007/s00405-008-0817-3 [doi]
4. Rapidis AD, Vermorken JB, Bourhis J (2008) Targeted therapies in head and neck cancer: past, present and future. RevRecent ClinTrials 3 (3):156-166
5. Watters AL, Epstein JB, Agulnik M (2011) Oral complications of targeted cancer therapies: a narrative literature review. Oral Oncol 47 (6):441-448. doi:S1368-8375(11)00125-4 [pii];10.1016/j.oraloncology.2011.03.028 [doi]
6. Lacouture ME, Anadkat MJ, Bensadoun RJ, Bryce J, Chan A, Epstein JB, Eaby-Sandy B, Murphy BA (2011) Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. SupportCare Cancer 19 (8):1079-1095. doi:10.1007/s00520-011-1197-6 [doi]
7. Elting LS, Keefe DM, Sonis ST, Garden AS, Spijkervet FK, Barasch A, Tishler RB, Canty TP, Kudrimoti MK, Vera-Llonch M (2008) Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer 113 (10):2704-2713. doi:10.1002/cncr.23898 [doi]
8. Cooperstein E, Gilbert J, Epstein JB, Dietrich MS, Bond SM, Ridner SH, Wells N, Cmelak A, Murphy BA (2012) Vanderbilt Head and Neck Symptom Survey version 2.0: report of the development and initial testing of a subscale for assessment of oral health. Head Neck 34 (6):797-804. doi:10.1002/hed.21816 [doi]
9. Hunter KU, Schipper M, Feng FY, Lyden T, Haxer M, Murdoch-Kinch CA, Cornwall B, Lee CS, Chepeha DB, Eisbruch A (2013) Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes. IntJRadiatOncolBiolPhys 85 (4):935-940. doi:S0360-3016(12)03450-5 [pii];10.1016/j.ijrobp.2012.08.030 [doi]
10. Raber-Durlacher JE, Scully C (2012) Oral cancer: comprehending the condition, causes, controversies, control and consequences. 14. Mucositis. DentUpdate 39 (2):145-147
11. Clarkson JE, Worthington HV, Furness S, McCabe M, Khalid T, Meyer S (2010) Interventions for treating oral mucositis for patients with cancer receiving treatment. CochraneDatabaseSystRev (8):CD001973. doi:10.1002/14651858.CD001973.pub4 [doi]
12. Worthington HV, Clarkson JE, Bryan G, Furness S, Glenny AM, Littlewood A, McCabe MG, Meyer S, Khalid T (2011) Interventions for preventing oral mucositis for patients with cancer receiving treatment. CochraneDatabaseSystRev (4):CD000978. doi:10.1002/14651858.CD000978.pub5 [doi]
13. Bjordal JM, Bensadoun RJ, Tuner J, Frigo L, Gjerde K, Lopes-Martins RA (2011) A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. SupportCare Cancer 19 (8):1069-1077. doi:10.1007/s00520-011-1202-0 [doi]
14. Bensadoun RJ, Nair RG (2012) Low-level laser therapy in the prevention and treatment of cancer therapy-induced mucositis: 2012 state of the art based on literature review and meta-analysis. CurrOpinOncol 24 (4):363-370. doi:10.1097/CCO.0b013e328352eaa3 [doi]
15. Migliorati C, Hewson I, Lalla RV, Antunes HS, Estilo CL, Hodgson B, Lopes NN, Schubert MM, Bowen J, Elad S (2013) Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. SupportCare Cancer 21 (1):333-341. doi:10.1007/s00520-012-1605-6 [doi]
16. Oberoi S, Zamperlini-Netto G, Beyene J, Treister NS, Sung L (2014) Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoS One 9 (9):e107418. doi:10.1371/journal.pone.0107418
17. Hodgson BD, Margolis DM, Salzman DE, Eastwood D, Tarima S, Williams LD, Sande JE, Vaughan WP, Whelan HT (2012) Amelioration of oral mucositis pain by NASA near-infrared light-emitting diodes in bone marrow transplant patients. SupportCare Cancer 20 (7):1405-1415. doi:10.1007/s00520-011-1223-8 [doi]
18. Hudson DE, Hudson DO, Wininger JM, Richardson BD (2013) Penetration of laser light at 808 and 980 nm in bovine tissue samples. PhotomedLaser Surg 31 (4):163-168. doi:10.1089/pho.2012.3284 [doi]
19. Bjordal JM, Johnson MI, Iversen V, Aimbire F, Lopes-Martins RA (2006) Low-level laser therapy in acute pain: a systematic review of possible mechanisms of action and clinical effects in randomized placebo-controlled trials. PhotomedLaser Surg 24 (2):158-168. doi:10.1089/pho.2006.24.158 [doi]
20. Hashmi JT, Huang YY, Sharma SK, Kurup DB, De TL, Carroll JD, Hamblin MR (2010) Effect of pulsing in low-level light therapy. Lasers SurgMed 42 (6):450-466. doi:10.1002/lsm.20950 [doi]
21. Mester E, Spiry T, Szende B, Tota JG (1971) Effect of laser rays on wound healing. AmJSurg 122 (4):532-535. doi:0002-9610(71)90482-X [pii]
22. Woodruff LD, Bounkeo JM, Brannon WM, Dawes KS, Barham CD, Waddell DL, Enwemeka CS (2004) The efficacy of laser therapy in wound repair: a meta-analysis of the literature. PhotomedLaser Surg 22 (3):241-247. doi:10.1089/1549541041438623 [doi]
23. Hawkins D, Abrahamse H (2005) Biological effects of helium-neon laser irradiation on normal and wounded human skin fibroblasts. PhotomedLaser Surg 23 (3):251-259. doi:10.1089/pho.2005.23.251 [doi]
24. Oron U, Yaakobi T, Oron A, Mordechovitz D, Shofti R, Hayam G, Dror U, Gepstein L, Wolf T, Haudenschild C, Haim SB (2001) Low-energy laser irradiation reduces formation of scar tissue after myocardial infarction in rats and dogs. Circulation 103 (2):296-301
25. Rizzi CF, Mauriz JL, Freitas Correa DS, Moreira AJ, Zettler CG, Filippin LI, Marroni NP, Gonzalez-Gallego J (2006) Effects of low-level laser therapy (LLLT) on the nuclear factor (NF)-kappaB signaling pathway in traumatized muscle. Lasers SurgMed 38 (7):704-713. doi:10.1002/lsm.20371 [doi]
26. Barolet D, Boucher A (2010) Prophylactic low-level light therapy for the treatment of hypertrophic scars and keloids: a case series. Lasers SurgMed 42 (6):597-601. doi:10.1002/lsm.20952 [doi]
27. Oliveira FA, Moraes AC, Paiva AP, Schinzel V, Correa-Costa M, Semedo P, Castoldi A, Cenedeze MA, Oliveira RS, Bastos MG, Camara NO, Sanders-Pinheiro H (2012) Low-level laser therapy decreases renal interstitial fibrosis. PhotomedLaser Surg 30 (12):705-713. doi:10.1089/pho.2012.3272 [doi]
28. Meneguzzo DT, Lopes LA, Pallota R, Soares-Ferreira L, Lopes-Martins RA, Ribeiro MS (2013) Prevention and treatment of mice paw edema by near-infrared low-level laser therapy on lymph nodes. Lasers MedSci 28 (3):973-980. doi:10.1007/s10103-012-1163-7 [doi]
29. Luo L, Sun Z, Zhang L, Li X, Dong Y, Liu TC (2013) Effects of low-level laser therapy on ROS homeostasis and expression of IGF-1 and TGF-beta1 in skeletal muscle during the repair process. Lasers MedSci 28 (3):725-734. doi:10.1007/s10103-012-1133-0 [doi]
30. Bjordal JM, Couppe C, Chow RT, Tuner J, Ljunggren EA (2003) A systematic review of low level laser therapy with location-specific doses for pain from chronic joint disorders. AustJPhysiother 49 (2):107-116
31. Chow RT, Johnson MI, Lopes-Martins RA, Bjordal JM (2009) Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials. Lancet 374 (9705):1897-1908. doi:S0140-6736(09)61522-1 [pii];10.1016/S0140-6736(09)61522-1 [doi]
32. Chow R, Armati P, Laakso EL, Bjordal JM, Baxter GD (2011) Inhibitory effects of laser irradiation on peripheral mammalian nerves and relevance to analgesic effects: a systematic review. PhotomedLaser Surg 29 (6):365-381. doi:10.1089/pho.2010.2928 [doi]
33. Song S, Zhou F, Chen WR (2012) Low-level laser therapy regulates microglial function through Src-mediated signaling pathways: implications for neurodegenerative diseases. JNeuroinflammation 9:219. doi:1742-2094-9-219 [pii];10.1186/1742-2094-9-219 [doi]
34. Huang YY, Gupta A, Vecchio D, de Arce VJ, Huang SF, Xuan W, Hamblin MR (2012) Transcranial low level laser (light) therapy for traumatic brain injury. JBiophotonics 5 (11-12):827-837. doi:10.1002/jbio.201200077 [doi]
35. Karu TI (2010) Multiple roles of cytochrome c oxidase in mammalian cells under action of red and IR-A radiation. IUBMBLife 62 (8):607-610. doi:10.1002/iub.359 [doi]
36. Khakh BS, Burnstock G (2009) The double life of ATP. SciAm 301 (6):84-90, 92
37. Murrell GA, Francis MJ, Bromley L (1990) Modulation of fibroblast proliferation by oxygen free radicals. BiochemJ 265 (3):659-665
38. Antunes F, Boveris A, Cadenas E (2004) On the mechanism and biology of cytochrome oxidase inhibition by nitric oxide. ProcNatlAcadSciUSA 101 (48):16774-16779. doi:0405368101 [pii];10.1073/pnas.0405368101 [doi]
39. Chung H, Dai T, Sharma SK, Huang YY, Carroll JD, Hamblin MR (2012) The nuts and bolts of low-level laser (light) therapy. AnnBiomedEng 40 (2):516-533. doi:10.1007/s10439-011-0454-7 [doi]
40. Karu TI, Kolyakov SF (2005) Exact action spectra for cellular responses relevant to phototherapy. PhotomedLaser Surg 23 (4):355-361. doi:10.1089/pho.2005.23.355 [doi]
41. Karu T (1989) Photobiology of low-power laser effects. Health Phys 56 (5):691-704
42. Assis L, Moretti AI, Abrahao TB, Cury V, Souza HP, Hamblin MR, Parizotto NA (2012) Low-level laser therapy (808 nm) reduces inflammatory response and oxidative stress in rat tibialis anterior muscle after cryolesion. Lasers SurgMed 44 (9):726-735. doi:10.1002/lsm.22077 [doi]
43. Karu TI, Pyatibrat LV, Kalendo GS (2004) Photobiological modulation of cell attachment via cytochrome c oxidase. PhotochemPhotobiolSci 3 (2):211-216. doi:10.1039/b306126d [doi]
44. Fujimaki Y, Shimoyama T, Liu Q, Umeda T, Nakaji S, Sugawara K (2003) Low-level laser irradiation attenuates production of reactive oxygen species by human neutrophils. JClinLaser MedSurg 21 (3):165-170. doi:10.1089/104454703321895635 [doi]
45. Silveira PC, da Silva LA, Pinho CA, De Souza PS, Ronsani MM, Scheffer DL, Pinho RA (2013) Effects of low-level laser therapy (GaAs) in an animal model of muscular damage induced by trauma. Lasers MedSci 28 (2):431-436. doi:10.1007/s10103-012-1075-6 [doi]
46. de Lima FM, Villaverde AB, Albertini R, Correa JC, Carvalho RL, Munin E, Araujo T, Silva JA, Aimbire F (2011) Dual Effect of low-level laser therapy (LLLT) on the acute lung inflammation induced by intestinal ischemia and reperfusion: Action on anti- and pro-inflammatory cytokines. Lasers SurgMed 43 (5):410-420. doi:10.1002/lsm.21053 [doi]
47. Lohr NL, Keszler A, Pratt P, Bienengraber M, Warltier DC, Hogg N (2009) Enhancement of nitric oxide release from nitrosyl hemoglobin and nitrosyl myoglobin by red/near infrared radiation: potential role in cardioprotection. JMolCell Cardiol 47 (2):256-263. doi:S0022-2828(09)00117-5 [pii];10.1016/j.yjmcc.2009.03.009 [doi]
48. Lopes NN, Plapler H, Chavantes MC, Lalla RV, Yoshimura EM, Alves MT (2009) Cyclooxygenase-2 and vascular endothelial growth factor expression in 5-fluorouracil-induced oral mucositis in hamsters: evaluation of two low-intensity laser protocols. SupportCare Cancer 17 (11):1409-1415. doi:10.1007/s00520-009-0603-9 [doi]
49. Lopes NN, Plapler H, Lalla RV, Chavantes MC, Yoshimura EM, da Silva MA, Alves MT (2010) Effects of low-level laser therapy on collagen expression and neutrophil infiltrate in 5-fluorouracil-induced oral mucositis in hamsters. Lasers SurgMed 42 (6):546-552. doi:10.1002/lsm.20920 [doi]
50. Mendenhall WM, Parsons JT, Buatti JM, Stringer SP, Million RR, Cassisi NJ (1995) Advances in radiotherapy for head and neck cancer. SeminSurgOncol 11 (3):256-264
51. Mancini ML, Sonis ST (2014) Mechanisms of cellular fibrosis associated with cancer regimen-related toxicities. Front Pharmacol 5:51. doi:10.3389/fphar.2014.00051 [doi]
52. Fillipin LI, Mauriz JL, Vedovelli K, Moreira AJ, Zettler CG, Lech O, Marroni NP, Gonzalez-Gallego J (2005) Low-level laser therapy (LLLT) prevents oxidative stress and reduces fibrosis in rat traumatized Achilles tendon. Lasers Surg Med 37 (4):293-300. doi:10.1002/lsm.20225
53. Lev-Tov H, Brody N, Siegel D, Jagdeo J (2013) Inhibition of fibroblast proliferation in vitro using low-level infrared light-emitting diodes. DermatolSurg 39 (3 Pt 1):422-425. doi:10.1111/dsu.12087 [doi]
54. Huang YY, Chen AC, Carroll JD, Hamblin MR (2009) Biphasic dose response in low level light therapy. DoseResponse 7 (4):358-383. doi:10.2203/dose-response.09-027.Hamblin [doi]
55. Sommer AP, Pinheiro AL, Mester AR, Franke RP, Whelan HT (2001) Biostimulatory windows in low-intensity laser activation: lasers, scanners, and NASA’s light-emitting diode array system. JClinLaser MedSurg 19 (1):29-33. doi:10.1089/104454701750066910 [doi]
56. World Association for Laser Therapy (WALT);
57. Gouvea de Lima A, Villar RC, de Castro G, Jr., Antequera R, Gil E, Rosalmeida MC, Federico MH, Snitcovsky IM (2012) Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study. Int J Radiat Oncol Biol Phys 82 (1):270-275. doi:10.1016/j.ijrobp.2010.10.012
58. Bjordal JM (2012) Low level laser therapy (LLLT) and World Association for Laser Therapy (WALT) dosage recommendations. Photomed Laser Surg 30 (2):61-62. doi:10.1089/pho.2012.9893
59. Jenkins PA, Carroll JD (2011) How to report low-level laser therapy (LLLT)/photomedicine dose and beam parameters in clinical and laboratory studies. PhotomedLaser Surg 29 (12):785-787. doi:10.1089/pho.2011.9895 [doi]
60. Guirro RR, Weis LC (2009) Radiant power determination of low-level laser therapy equipment and characterization of its clinical use procedures. PhotomedLaser Surg 27 (4):633-639. doi:10.1089/pho.2008.2361 [doi]
61. Simpson DR, Mell LK, Cohen EE (2015) Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck. Oral Oncol 51 (4):291-298. doi:10.1016/j.oraloncology.2014.11.012
62. Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, Kearsley JH, Li Y (2013) Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance. Cell Death Dis 4:e875. doi:10.1038/cddis.2013.407
63. Nagata Y, Takahashi A, Ohnishi K, Ota I, Ohnishi T, Tojo T, Taniguchi S (2010) Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status. Int J Oncol 37 (4):1001-1010
64. Pellicioli AC, Martins MD, Dillenburg CS, Marques MM, Squarize CH, Castilho RM (2014) Laser phototherapy accelerates oral keratinocyte migration through the modulation of the mammalian target of rapamycin signaling pathway. J Biomed Opt 19 (2):028002. doi:10.1117/1.jbo.19.2.028002
65. Sperandio FF, Giudice FS, Correa L, Pinto DS, Jr., Hamblin MR, de Sousa SC (2013) Low-level laser therapy can produce increased aggressiveness of dysplastic and oral cancer cell lines by modulation of Akt/mTOR signaling pathway. JBiophotonics. doi:10.1002/jbio.201300015 [doi]
66. Pardali K, Moustakas A (2007) Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 1775 (1):21-62. doi:10.1016/j.bbcan.2006.06.004
67. Siegel PM, Massague J (2003) Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 3 (11):807-821. doi:10.1038/nrc1208
68. Prime SS, Davies M, Pring M, Paterson IC (2004) The role of TGF-beta in epithelial malignancy and its relevance to the pathogenesis of oral cancer (part II). Crit Rev Oral Biol Med 15 (6):337-347
69. Hwang YS, Park KK, Chung WY (2014) Stromal transforming growth factor-beta 1 is crucial for reinforcing the invasive potential of low invasive cancer. Arch Oral Biol 59 (7):687-694. doi:10.1016/j.archoralbio.2014.03.017
70. Dang Y, Liu B, Liu L, Ye X, Bi X, Zhang Y, Gu J (2011) The 800-nm diode laser irradiation induces skin collagen synthesis by stimulating TGF-beta/Smad signaling pathway. Lasers Med Sci 26 (6):837-843. doi:10.1007/s10103-011-0985-z
71. Chen YK, Huang AH, Cheng PH, Yang SH, Lin LM (2013) Overexpression of Smad proteins, especially Smad7, in oral epithelial dysplasias. Clin Oral Investig 17 (3):921-932. doi:10.1007/s00784-012-0756-7
72. Dhillon AS, Hagan S, Rath O, Kolch W (2007) MAP kinase signalling pathways in cancer. Oncogene 26 (22):3279-3290. doi:10.1038/sj.onc.1210421
73. Cui X, Li S, Li T, Pang X, Zhang S, Jin J, Hu J, Liu C, Yang L, Peng H, Jiang J, Liang W, Suo J, Li F, Chen Y (2014) Significance of elevated ERK expression and its positive correlation with EGFR in Kazakh patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 7 (5):2382-2391
74. Feng J, Zhang Y, Xing D (2012) Low-power laser irradiation (LPLI) promotes VEGF expression and vascular endothelial cell proliferation through the activation of ERK/Sp1 pathway. Cell Signal 24 (6):1116-1125. doi:10.1016/j.cellsig.2012.01.013
75. Kawano Y, Utsunomiya-Kai Y, Kai K, Miyakawa I, Ohshiro T, Narahara H (2012) The production of VEGF involving MAP kinase activation by low level laser therapy in human granulosa cells. Laser Ther 21 (4):269-274. doi:10.5978/islsm.12-OR-15
76. Gupta A, Keshri GK, Yadav A, Gola S, Chauhan S, Salhan AK, Bala Singh S (2014) Superpulsed (Ga-As, 904 nm) low-level laser therapy (LLLT) attenuates inflammatory response and enhances healing of burn wounds. J Biophotonics 9999 (9999). doi:10.1002/jbio.201400058
77. Kushibiki T, Hirasawa T, Okawa S, Ishihara M (2013) Regulation of miRNA Expression by Low-Level Laser Therapy (LLLT) and Photodynamic Therapy (PDT). Int J Mol Sci 14 (7):13542-13558. doi:10.3390/ijms140713542
78. Png KJ, Halberg N, Yoshida M, Tavazoie SF (2012) A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481 (7380):190-194. doi:10.1038/nature10661
79. Shabbir M, Ryten M, Thompson C, Mikhailidis D, Burnstock G (2008) Purinergic receptor-mediated effects of ATP in high-grade bladder cancer. BJUInt 101 (1):106-112. doi:BJU7286 [pii];10.1111/j.1464-410X.2007.07286.x [doi]
80. Marchesini R, Dasdia T, Melloni E, Rocca E (1989) Effect of low-energy laser irradiation on colony formation capability in different human tumor cells in vitro. Lasers SurgMed 9 (1):59-62
81. Kreisler M, Christoffers AB, Willershausen B, d’Hoedt B (2003) Low-level 809 nm GaAlAs laser irradiation increases the proliferation rate of human laryngeal carcinoma cells in vitro. Lasers MedSci 18 (2):100-103. doi:10.1007/s10103-003-0265-7 [doi]
82. de Castro JL, Pinheiro AL, Werneck CE, Soares CP (2005) The effect of laser therapy on the proliferation of oral KB carcinoma cells: an in vitro study. PhotomedLaser Surg 23 (6):586-589. doi:10.1089/pho.2005.23.586 [doi]
83. Schaffer M, Sroka R, Fuchs C, Schrader-Reichardt U, Schaffer PM, Busch M, Duhmke E (1997) Biomodulative effects induced by 805 nm laser light irradiation of normal and tumor cells. JPhotochemPhotobiolB 40 (3):253-257. doi:S1011-1344(97)00065-1 [pii]
84. Pinheiro AL, Carneiro NS, Vieira AL, Brugnera A, Jr., Zanin FA, Barros RA, Silva PS (2002) Effects of low-level laser therapy on malignant cells: in vitro study. JClinLaser MedSurg 20 (1):23-26. doi:10.1089/104454702753474977 [doi]
85. Werneck CE, Pinheiro AL, Pacheco MT, Soares CP, de Castro JL (2005) Laser light is capable of inducing proliferation of carcinoma cells in culture: a spectroscopic in vitro study. PhotomedLaser Surg 23 (3):300-303. doi:10.1089/pho.2005.23.300 [doi]
86. Renno AC, McDonnell PA, Parizotto NA, Laakso EL (2007) The effects of laser irradiation on osteoblast and osteosarcoma cell proliferation and differentiation in vitro. PhotomedLaser Surg 25 (4):275-280. doi:10.1089/pho.2007.2055 [doi]
87. Powell K, Low P, McDonnell PA, Laakso EL, Ralph SJ (2010) The effect of laser irradiation on proliferation of human breast carcinoma, melanoma, and immortalized mammary epithelial cells. PhotomedLaser Surg 28 (1):115-123. doi:10.1089/pho.2008.2445 [doi]
88. Gomes Henriques AC, Ginani F, Oliveira RM, Keesen TS, Galvao Barboza CA, Oliveira Rocha HA, de Castro JF, Della Coletta R, de Almeida Freitas R (2014) Low-level laser therapy promotes proliferation and invasion of oral squamous cell carcinoma cells. Lasers Med Sci 29 (4):1385-1395. doi:10.1007/s10103-014-1535-2
89. Coombe AR, Ho CT, Darendeliler MA, Hunter N, Philips JR, Chapple CC, Yum LW (2001) The effects of low level laser irradiation on osteoblastic cells. ClinOrthodRes 4 (1):3-14. doi:cor040102 [pii]
90. Liu YH, Cheng CC, Ho CC, Pei RJ, Lee KY, Yeh KT, Chan Y, Lai YS (2004) Effects of diode 808 nm GaAlAs low-power laser irradiation on inhibition of the proliferation of human hepatoma cells in vitro and their possible mechanism. Res Commun Mol Pathol Pharmacol 115-116:185-201
91. Sroka R, Schaffer M, Fuchs C, Pongratz T, Schrader-Reichard U, Busch M, Schaffer PM, Duhmke E, Baumgartner R (1999) Effects on the mitosis of normal and tumor cells induced by light treatment of different wavelengths. Lasers SurgMed 25 (3):263-271. doi:10.1002/(SICI)1096-9101(1999)25:3<263::AID-LSM11>3.0.CO;2-T [pii]
92. Murayama H, Sadakane K, Yamanoha B, Kogure S (2012) Low-power 808-nm laser irradiation inhibits cell proliferation of a human-derived glioblastoma cell line in vitro. Lasers Med Sci 27 (1):87-93. doi:10.1007/s10103-011-0924-z
93. Al-Watban FA, Andres BL (2012) Laser biomodulation of normal and neoplastic cells. Lasers Med Sci 27 (5):1039-1043. doi:10.1007/s10103-011-1040-9
94. Crous AM, Abrahamse H (2013) Lung cancer stem cells and low-intensity laser irradiation: a potential future therapy? Stem Cell Res Ther 4 (5):129. doi:10.1186/scrt340
95. Mester E, Szende B, Gartner P (1968) [The effect of laser beams on the growth of hair in mice]. RadiobiolRadiother(Berl) 9 (5):621-626
96. Schartinger VH, Galvan O, Riechelmann H, Dudas J (2012) Differential responses of fibroblasts, non-neoplastic epithelial cells, and oral carcinoma cells to low-level laser therapy. SupportCare Cancer 20 (3):523-529. doi:10.1007/s00520-011-1113-0 [doi]
97. Tsai SR, Yin R, Huang YY, Sheu BC, Lee SC, Hamblin MR (2015) Low-level light therapy potentiates NPe6-mediated photodynamic therapy in a human osteosarcoma cell line via increased ATP. Photodiagnosis Photodyn Ther 12 (1):123-130. doi:10.1016/j.pdpdt.2014.10.009
98. Schaffer M, Bonel H, Sroka R, Schaffer PM, Busch M, Reiser M, Duhmke E (2000) Effects of 780 nm diode laser irradiation on blood microcirculation: preliminary findings on time-dependent T1-weighted contrast-enhanced magnetic resonance imaging (MRI). J Photochem Photobiol B 54 (1):55-60
99. de CMJ, Pinheiro AN, de Oliveira SC, Aciole GT, Sousa JA, Canguss MC, Dos Santos JN (2011) Influence of laser phototherapy (lambda660 nm) on the outcome of oral chemical carcinogenesis on the hamster cheek pouch model: histological study. PhotomedLaser Surg 29 (11):741-745. doi:10.1089/pho.2010.2896 [doi]
100. Frigo L, Luppi JS, Favero GM, Maria DA, Penna SC, Bjordal JM, Bensadoun RJ, Lopes-Martins RA (2009) The effect of low-level laser irradiation (In-Ga-Al-AsP – 660 nm) on melanoma in vitro and in vivo. BMCCancer 9:404. doi:1471-2407-9-404 [pii];10.1186/1471-2407-9-404 [doi]
101. Myakishev-Rempel M, Stadler I, Brondon P, Axe DR, Friedman M, Nardia FB, Lanzafame R (2012) A preliminary study of the safety of red light phototherapy of tissues harboring cancer. PhotomedLaser Surg 30 (9):551-558. doi:10.1089/pho.2011.3186 [doi]
102. Liu TC, Zhang J, Li XE (2013) The balance between normal and tumor tissues in phototherapy of tissues harboring cancer. Photomed Laser Surg 31 (3):93-94. doi:10.1089/pho.2012.3355
103. Antunes HS, Herchenhorn D, Small IA, Araujo CM, Viegas CM, Cabral E, Rampini MP, Rodrigues PC, Silva TG, Ferreira EM, Dias FL, Ferreira CG (2013) Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 109 (2):297-302. doi:10.1016/j.radonc.2013.08.010
104. Sonis ST (2004) A biological approach to mucositis. The journal of supportive oncology 2 (1):21-32; discussion 35-26
105. Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV (2013) Emerging evidence on the pathobiology of mucositis. SupportCare Cancer. doi:10.1007/s00520-013-1900-x [doi]
106. Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S (2014) MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120 (10):1453-1461. doi:10.1002/cncr.28592
107. Dorr W, Hendry JH (2001) Consequential late effects in normal tissues. RadiotherOncol 61 (3):223-231. doi:S0167814001004297 [pii]
108. Hymes SR, Strom EA, Fife C (2006) Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. JAmAcadDermatol 54 (1):28-46. doi:S0190-9622(05)02707-6 [pii];10.1016/j.jaad.2005.08.054 [doi]
109. Kim JH, Kolozsvary AJ, Jenrow KA, Brown SL (2013) Mechanisms of radiation-induced skin injury and implications for future clinical trials. IntJRadiatBiol 89 (5):311-318. doi:10.3109/09553002.2013.765055 [doi]
110. Bernier J, Bonner J, Vermorken JB, Bensadoun RJ, Dummer R, Giralt J, Kornek G, Hartley A, Mesia R, Robert C, Segaert S, Ang KK (2008) Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. AnnOncol 19 (1):142-149. doi:mdm400 [pii];10.1093/annonc/mdm400 [doi]
111. Martin M, Lefaix J, Delanian S (2000) TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target? IntJRadiatOncolBiolPhys 47 (2):277-290. doi:S0360301600004351 [pii]
112. Westbury CB, Yarnold JR (2012) Radiation fibrosis — current clinical and therapeutic perspectives. ClinOncol(RCollRadiol) 24 (10):657-672. doi:S0936-6555(12)00122-7 [pii];10.1016/j.clon.2012.04.001 [doi]
113. Avci P, Gupta A, Sadasivam M, Vecchio D, Pam Z, Pam N, Hamblin MR (2013) Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. SeminCutanMedSurg 32 (1):41-52
114. Costa MM, Silva SB, Quinto AL, Pasquinelli PF, de Queiroz dos Santos V, de Cassia Santos G, Veiga DF (2014) Phototherapy 660 nm for the prevention of radiodermatitis in breast cancer patients receiving radiation therapy: study protocol for a randomized controlled trial. Trials 15:330. doi:10.1186/1745-6215-15-330
115. Rezvani M, Robbins ME, Hopewell JW, Whitehouse EM (1993) Modification of late dermal necrosis in the pig by treatment with multi-wavelength light. The British journal of radiology 66 (782):145-149
116. DeLand MM, Weiss RA, McDaniel DH, Geronemus RG (2007) Treatment of radiation-induced dermatitis with light-emitting diode (LED) photomodulation. Lasers Surg Med 39 (2):164-168. doi:10.1002/lsm.20455
117. Fife D, Rayhan DJ, Behnam S, Ortiz A, Elkeeb L, Aquino L, Eduardo Roa D, Ramsinghani N, Kuo J, Newcomb R, Zachary CB, Kelly KM (2010) A randomized, controlled, double-blind study of light emitting diode photomodulation for the prevention of radiation dermatitis in patients with breast cancer. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al] 36 (12):1921-1927. doi:10.1111/j.1524-4725.2010.01801.x
118. Raber-Durlacher JE, Brennan MT, Verdonck-de Leeuw IM, Gibson RJ, Eilers JG, Waltimo T, Bots CP, Michelet M, Sollecito TP, Rouleau TS, Sewnaik A, Bensadoun RJ, Fliedner MC, Silverman S, Jr., Spijkervet FK (2012) Swallowing dysfunction in cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20 (3):433-443. doi:10.1007/s00520-011-1342-2
119. Russi EG, Corvo R, Merlotti A, Alterio D, Franco P, Pergolizzi S, De S, V, Ruo Redda MG, Ricardi U, Paiar F, Bonomo P, Merlano MC, Zurlo V, Chiesa F, Sanguineti G, Bernier J (2012) Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology. Cancer TreatRev 38 (8):1033-1049. doi:S0305-7372(12)00079-5 [pii];10.1016/j.ctrv.2012.04.002 [doi]
120. Leslie P, Carding PN, Wilson JA (2003) Investigation and management of chronic dysphagia. BMJ (Clinical research ed) 326 (7386):433-436. doi:10.1136/bmj.326.7386.433 [doi];326/7386/433 [pii]
121. Nguyen NP, Moltz CC, Frank C, Vos P, Smith HJ, Karlsson U, Dutta S, Midyett FA, Barloon J, Sallah S (2004) Dysphagia following chemoradiation for locally advanced head and neck cancer. AnnOncol 15 (3):383-388
122. Nguyen NP, Frank C, Moltz CC, Vos P, Smith HJ, Bhamidipati PV, Karlsson U, Nguyen PD, Alfieri A, Nguyen LM, Lemanski C, Chan W, Rose S, Sallah S (2006) Aspiration rate following chemoradiation for head and neck cancer: an underreported occurrence. RadiotherOncol 80 (3):302-306. doi:S0167-8140(06)00310-0 [pii];10.1016/j.radonc.2006.07.031 [doi]
123. Mittal BB, Pauloski BR, Haraf DJ, Pelzer HJ, Argiris A, Vokes EE, Rademaker A, Logemann JA (2003) Swallowing dysfunction–preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. IntJRadiatOncolBiolPhys 57 (5):1219-1230. doi:S0360301603014548 [pii]
124. Langmore SE (2003) Evaluation of oropharyngeal dysphagia: which diagnostic tool is superior? CurrOpinOtolaryngolHead Neck Surg 11 (6):485-489
125. Murphy BA, Gilbert J (2009) Dysphagia in head and neck cancer patients treated with radiation: assessment, sequelae, and rehabilitation. SeminRadiatOncol 19 (1):35-42. doi:S1053-4296(08)00062-3 [pii];10.1016/j.semradonc.2008.09.007 [doi]
126. Murphy BA, Dietrich MS, Wells N, Dwyer K, Ridner SH, Silver HJ, Gilbert J, Chung CH, Cmelak A, Burkey B, Yarbrough WG, Sinard R, Netterville J (2010) Reliability and validity of the Vanderbilt Head and Neck Symptom Survey: a tool to assess symptom burden in patients treated with chemoradiation. Head Neck 32 (1):26-37. doi:10.1002/hed.21143 [doi]
127. van der Molen L, van Rossum MA, Burkhead LM, Smeele LE, Rasch CR, Hilgers FJ (2011) A randomized preventive rehabilitation trial in advanced head and neck cancer patients treated with chemoradiotherapy: feasibility, compliance, and short-term effects. Dysphagia 26 (2):155-170. doi:10.1007/s00455-010-9288-y [doi]
128. Ganzer H, Touger-Decker R, Parrott JS, Murphy BA, Epstein JB, Huhmann MB (2013) Symptom burden in head and neck cancer: impact upon oral energy and protein intake. SupportCare Cancer 21 (2):495-503. doi:10.1007/s00520-012-1542-4 [doi]
129. Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ (2008) Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. JClinOncol 26 (22):3770-3776. doi:26/22/3770 [pii];10.1200/JCO.2007.14.6647 [doi]
130. Nguyen NP, Moltz CC, Frank C, Millar C, Smith HJ, Dutta S, Nguyen PD, Nguyen LM, Lemanski C, Ludin A, Jo BH, Sallah S (2007) Effectiveness of the cough reflex in patients with aspiration following radiation for head and neck cancer. Lung 185 (5):243-248. doi:10.1007/s00408-007-9016-z [doi]
131. Eisbruch A, Lyden T, Bradford CR, Dawson LA, Haxer MJ, Miller AE, Teknos TN, Chepeha DB, Hogikyan ND, Terrell JE, Wolf GT (2002) Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. IntJRadiatOncolBiolPhys 53 (1):23-28. doi:S0360301602027128 [pii]
132. Langendijk JA, Doornaert P, Rietveld DH, Verdonck-de Leeuw IM, Leemans CR, Slotman BJ (2009) A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. RadiotherOncol 90 (2):189-195. doi:S0167-8140(09)00005-X [pii];10.1016/j.radonc.2008.12.017 [doi]
133. Roe JW, Carding PN, Dwivedi RC, Kazi RA, Rhys-Evans PH, Harrington KJ, Nutting CM (2010) Swallowing outcomes following Intensity Modulated Radiation Therapy (IMRT) for head & neck cancer – a systematic review. Oral Oncol 46 (10):727-733. doi:S1368-8375(10)00228-9 [pii];10.1016/j.oraloncology.2010.07.012 [doi]
134. van der Molen L, Heemsbergen WD, de JR, van Rossum MA, Smeele LE, Rasch CR, Hilgers FJ (2013) Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures. RadiotherOncol 106 (3):364-369. doi:S0167-8140(13)00084-4 [pii];10.1016/j.radonc.2013.03.005 [doi]
135. Kraaijenga SA, van der Molen L, Stuiver MM, Teertstra HJ, Hilgers FJ, van den Brekel MW (2015) Effects of Strengthening Exercises on Swallowing Musculature and Function in Senior Healthy Subjects: a Prospective Effectiveness and Feasibility Study. Dysphagia. doi:10.1007/s00455-015-9611-8
136. Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Vadhiraja BM (2012) Low level laser therapy for concurrent chemoradiotherapy induced oral mucositis in head and neck cancer patients – a triple blinded randomized controlled trial. RadiotherOncol 104 (3):349-354. doi:S0167-8140(12)00313-1 [pii];10.1016/j.radonc.2012.06.011 [doi]
137. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napenas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von B, I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT (2010) A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. SupportCare Cancer 18 (8):1039-1060. doi:10.1007/s00520-010-0827-8 [doi]
138. Pedersen AM, Bardow A, Jensen SB, Nauntofte B (2002) Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral Dis 8 (3):117-129
139. Vissink A, Mitchell JB, Baum BJ, Limesand KH, Jensen SB, Fox PC, Elting LS, Langendijk JA, Coppes RP, Reyland ME (2010) Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers. IntJRadiatOncolBiolPhys 78 (4):983-991. doi:S0360-3016(10)00907-7 [pii];10.1016/j.ijrobp.2010.06.052 [doi]
140. Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P (2001) Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 23 (5):389-398. doi:10.1002/hed.1049 [pii]
141. Shiboski CH, Hodgson TA, Ship JA, Schiodt M (2007) Management of salivary hypofunction during and after radiotherapy. Oral SurgOral MedOral PatholOral RadiolEndod 103 Suppl:S66-19. doi:S1079-2104(06)00875-4 [pii];10.1016/j.tripleo.2006.11.013 [doi]
142. Burlage FR, Coppes RP, Meertens H, Stokman MA, Vissink A (2001) Parotid and submandibular/sublingual salivary flow during high dose radiotherapy. RadiotherOncol 61 (3):271-274. doi:S0167814001004273 [pii]
143. Avila JL, Grundmann O, Burd R, Limesand KH (2009) Radiation-induced salivary gland dysfunction results from p53-dependent apoptosis. IntJRadiatOncolBiolPhys 73 (2):523-529. doi:S0360-3016(08)03536-0 [pii];10.1016/j.ijrobp.2008.09.036 [doi]
144. Vissink A, van Luijk P, Langendijk JA, Coppes RP (2015) Current ideas to reduce or salvage radiation damage to salivary glands. Oral diseases 21 (1):e1-10. doi:10.1111/odi.12222
145. Loncar B, Stipetic MM, Baricevic M, Risovic D (2011) The effect of low-level laser therapy on salivary glands in patients with xerostomia. PhotomedLaser Surg 29 (3):171-175. doi:10.1089/pho.2010.2792 [doi]
146. Vidovic JD, Lukac J, Cekic-Arambasin A, Vidovic A, Canjuga I, Sikora M, Carek A, Ledinsky M (2010) Effects of low-level laser treatment on mouth dryness. CollAntropol 34 (3):1039-1043
147. Plavnik LM, De Crosa ME, Malberti AI (2003) Effect of low-power radiation (helium/neon) upon submandibulary glands. Journal of clinical laser medicine & surgery 21 (4):219-225. doi:10.1089/104454703768247792
148. Takeda Y (1988) Irradiation effect of low-energy laser on rat submandibular salivary gland. Journal of oral pathology 17 (2):91-94
149. Simoes A, Nicolau J, de Souza DN, Ferreira LS, de Paula EC, Apel C, Gutknecht N (2008) Effect of defocused infrared diode laser on salivary flow rate and some salivary parameters of rats. ClinOral Investig 12 (1):25-30. doi:10.1007/s00784-007-0135-y [doi]
150. Simoes A, de CL, de Souza DN, de Matos JA, Freitas PM, Nicolau J (2010) Laser phototherapy as topical prophylaxis against radiation-induced xerostomia. PhotomedLaser Surg 28 (3):357-363. doi:10.1089/pho.2009.2486 [doi]
151. Cowen D, Tardieu C, Schubert M, Peterson D, Resbeut M, Faucher C, Franquin JC (1997) Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial. Int J Radiat Oncol Biol Phys 38 (4):697-703
152. Arbabi-Kalati F, Arbabi-Kalati F, Moridi T (2013) Evaluation of the effect of low level laser on prevention of chemotherapy-induced mucositis. Acta medica Iranica 51 (3):157-162
153. Oton-Leite AF, Elias LS, Morais MO, Pinezi JC, Leles CR, Silva MA, Mendonca EF (2013) Effect of low level laser therapy in the reduction of oral complications in patients with cancer of the head and neck submitted to radiotherapy. Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry 33 (6):294-300. doi:10.1111/j.1754-4505.2012.00303.x
154. Saleh J, Figueiredo MA, Cherubini K, Braga-Filho A, Salum FG (2014) Effect of low-level laser therapy on radiotherapy-induced hyposalivation and xerostomia: a pilot study. Photomed Laser Surg 32 (10):546-552. doi:10.1089/pho.2014.3741
155. Boltong A, Aranda S, Keast R, Wynne R, Francis PA, Chirgwin J, Gough K (2014) A prospective cohort study of the effects of adjuvant breast cancer chemotherapy on taste function, food liking, appetite and associated nutritional outcomes. PLoS One 9 (7):e103512. doi:10.1371/journal.pone.0103512
156. Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, Ohrn KE, Elting LS, Spijkervet FK, Brennan MT (2010) A systematic review of dysgeusia induced by cancer therapies. SupportCare Cancer 18 (8):1081-1087. doi:10.1007/s00520-010-0902-1 [doi]
157. Ohrn KE, Wahlin YB, Sjoden PO (2001) Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications. SupportCare Cancer 9 (4):247-257
158. Epstein JB, Barasch A (2010) Taste disorders in cancer patients: pathogenesis, and approach to assessment and management. Oral Oncol 46 (2):77-81. doi:S1368-8375(09)00977-4 [pii];10.1016/j.oraloncology.2009.11.008 [doi]
159. Yamashita H, Nakagawa K, Nakamura N, Abe K, Asakage T, Ohmoto M, Okada S, Matsumoto I, Hosoi Y, Sasano N, Yamakawa S, Ohtomo K (2006) Relation between acute and late irradiation impairment of four basic tastes and irradiated tongue volume in patients with head-and-neck cancer. IntJRadiatOncolBiolPhys 66 (5):1422-1429. doi:S0360-3016(06)02764-7 [pii];10.1016/j.ijrobp.2006.08.037 [doi]
160. Romeo U, Del VA, Capocci M, Maggiore C, Ripari M (2010) The low level laser therapy in the management of neurological burning mouth syndrome. A pilot study. AnnStomatol(Roma) 1 (1):14-18
161. Dijkstra PU, Huisman PM, Roodenburg JL (2006) Criteria for trismus in head and neck oncology. IntJOral MaxillofacSurg 35 (4):337-342. doi:S0901-5027(05)00273-0 [pii];10.1016/j.ijom.2005.08.001 [doi]
162. Bensadoun RJ, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, Brennan MT (2010) A systematic review of trismus induced by cancer therapies in head and neck cancer patients. SupportCare Cancer 18 (8):1033-1038. doi:10.1007/s00520-010-0847-4 [doi]
163. Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP (2003) Oral sequelae of head and neck radiotherapy. Crit RevOral BiolMed 14 (3):199-212. doi:14/3/199 [pii]
164. Teguh DN, Levendag PC, Voet P, van der Est H, Noever I, de KW, van RP, Schmitz PI, Heijmen BJ (2008) Trismus in patients with oropharyngeal cancer: relationship with dose in structures of mastication apparatus. Head Neck 30 (5):622-630. doi:10.1002/hed.20760 [doi]
165. Goldstein M, Maxymiw WG, Cummings BJ, Wood RE (1999) The effects of antitumor irradiation on mandibular opening and mobility: a prospective study of 58 patients. Oral SurgOral MedOral PatholOral RadiolEndod 88 (3):365-373. doi:S1079-2104(99)70044-2 [pii]
166. Wang CJ, Huang EY, Hsu HC, Chen HC, Fang FM, Hsiung CY (2005) The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer. Laryngoscope 115 (8):1458-1460. doi:00005537-200508000-00024 [pii];10.1097/01.mlg.0000171019.80351.46 [doi]
167. Dijkstra PU, Kalk WW, Roodenburg JL (2004) Trismus in head and neck oncology: a systematic review. Oral Oncol 40 (9):879-889. doi:10.1016/j.oraloncology.2004.04.003 [doi];S1368837504000910 [pii]
168. Carnaby-Mann G, Crary MA, Schmalfuss I, Amdur R (2012) “Pharyngocise”: randomized controlled trial of preventative exercises to maintain muscle structure and swallowing function during head-and-neck chemoradiotherapy. Int J Radiat Oncol Biol Phys 83 (1):210-219. doi:10.1016/j.ijrobp.2011.06.1954
169. Carrillo JS, Calatayud J, Manso FJ, Barberia E, Martinez JM, Donado M (1990) A randomized double-blind clinical trial on the effectiveness of helium-neon laser in the prevention of pain, swelling and trismus after removal of impacted third molars. International dental journal 40 (1):31-36
170. Aras MH, Gungormus M (2010) Placebo-controlled randomized clinical trial of the effect two different low-level laser therapies (LLLT)–intraoral and extraoral–on trismus and facial swelling following surgical extraction of the lower third molar. Lasers Med Sci 25 (5):641-645. doi:10.1007/s10103-009-0684-1
171. Chrcanovic BR, Reher P, Sousa AA, Harris M (2010) Osteoradionecrosis of the jaws–a current overview–part 1: Physiopathology and risk and predisposing factors. Oral MaxillofacSurg 14 (1):3-16. doi:10.1007/s10006-009-0198-9 [doi]
172. Epstein J, van der Meij E, McKenzie M, Wong F, Lepawsky M, Stevenson-Moore P (1997) Postradiation osteonecrosis of the mandible: a long-term follow-up study. Oral SurgOral MedOral PatholOral RadiolEndod 83 (6):657-662. doi:S1079-2104(97)90314-0 [pii]
173. Delanian S, Lefaix JL (2004) The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. RadiotherOncol 73 (2):119-131. doi:S0167-8140(04)00393-7 [pii];10.1016/j.radonc.2004.08.021 [doi]
174. Bagan JV, Jimenez Y, Hernandez S, Murillo J, Diaz JM, Poveda R, Carbonell E, Sanchis JM, Gavalda C, Scully C (2009) Osteonecrosis of the jaws by intravenous bisphosphonates and osteoradionecrosis: a comparative study. MedOral PatolOral CirBucal 14 (12):e616-e619. doi:1278 [pii]
175. Madrid C, Abarca M, Bouferrache K (2010) Osteoradionecrosis: an update. Oral Oncol 46 (6):471-474. doi:S1368-8375(10)00108-9 [pii];10.1016/j.oraloncology.2010.03.017 [doi]
176. Schuurhuis JM, Stokman MA, Witjes MJ, Dijkstra PU, Vissink A, Spijkervet FK (2015) Evidence supporting pre-radiation elimination of oral foci of infection in head and neck cancer patients to prevent oral sequelae. A systematic review. Oral Oncol 51 (3):212-220. doi:10.1016/j.oraloncology.2014.11.017
177. Kurzweg T, Mockelmann N, Laban S, Knecht R (2012) Current treatment options for recurrent/metastatic head and neck cancer: a post-ASCO 2011 update and review of last year’s literature. EurArchOtorhinolaryngol 269 (10):2157-2167. doi:10.1007/s00405-012-1998-3 [doi]
178. Estilo CL, Fornier M, Farooki A, Carlson D, Bohle G, III, Huryn JM (2008) Osteonecrosis of the jaw related to bevacizumab. JClinOncol 26 (24):4037-4038. doi:26/24/4037 [pii];10.1200/JCO.2007.15.5424 [doi]
179. Brunamonti BP, Bandelloni R, Labanca M, Buffoli B, Rezzani R, Rodella LF (2012) Osteonecrosis of the jaws and bevacizumab therapy: a case report. IntJImmunopatholPharmacol 25 (3):789-791. doi:28 [pii]
180. Sivolella S, Lumachi F, Stellini E, Favero L (2013) Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease. Anticancer Res 33 (5):1793-1797. doi:33/5/1793 [pii]
181. Santos-Silva AR, Belizario Rosa GA, Castro JG, Dias RB, Prado Ribeiro AC, Brandao TB (2013) Osteonecrosis of the mandible associated with bevacizumab therapy. Oral SurgOral MedOral PatholOral Radiol 115 (6):e32-e36. doi:S2212-4403(13)00053-9 [pii];10.1016/j.oooo.2013.02.001 [doi]
182. Koch FP, Walter C, Hansen T, Jager E, Wagner W (2011) Osteonecrosis of the jaw related to sunitinib. Oral MaxillofacSurg 15 (1):63-66. doi:10.1007/s10006-010-0224-y [doi]
183. Nicolatou-Galitis O, Migkou M, Psyrri A, Bamias A, Pectasides D, Economopoulos T, Raber-Durlacher JE, Dimitriadis G, Dimopoulos MA (2012) Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications. Oral SurgOral MedOral PatholOral Radiol 113 (2):234-238. doi:S1079-2104(11)00622-6 [pii];10.1016/j.tripleo.2011.08.024 [doi]
184. Da Cunha SS, Sarmento V, Ramalho LM, De Almeida D, Veeck EB, Da Costa NP, Mattos A, Marques AM, Gerbi M, Freitas AC (2007) Effect of laser therapy on bone tissue submitted to radiotherapy: experimental study in rats. Photomed Laser Surg 25 (3):197-204. doi:10.1089/pho.2007.2002
185. El-Maghraby EM, El-Rouby DH, Saafan AM (2013) Assessment of the effect of low-energy diode laser irradiation on gamma irradiated rats’ mandibles. Arch Oral Biol 58 (7):796-805. doi:10.1016/j.archoralbio.2012.10.003
186. Batista JD, Zanetta-Barbosa D, Cardoso SV, Dechichi P, Rocha FS, Pagnoncelli RM (2014) Effect of low-level laser therapy on repair of the bone compromised by radiotherapy. Lasers Med Sci 29 (6):1913-1918. doi:10.1007/s10103-014-1602-8
187. Scoletta M, Arduino PG, Reggio L, Dalmasso P, Mozzati M (2010) Effect of low-level laser irradiation on bisphosphonate-induced osteonecrosis of the jaws: preliminary results of a prospective study. PhotomedLaser Surg 28 (2):179-184. doi:10.1089/pho.2009.2501 [doi]
188. Romeo U, Galanakis A, Marias C, Vecchio AD, Tenore G, Palaia G, Vescovi P, Polimeni A (2011) Observation of pain control in patients with bisphosphonate-induced osteonecrosis using low level laser therapy: preliminary results. PhotomedLaser Surg 29 (7):447-452. doi:10.1089/pho.2010.2835 [doi]
189. Vescovi P, Merigo E, Meleti M, Manfredi M, Fornaini C, Nammour S (2012) Surgical Approach and Laser Applications in BRONJ Osteoporotic and Cancer Patients. JOsteoporos 2012:585434. doi:10.1155/2012/585434 [doi]
190. Vescovi P, Giovannacci I, Merigo E, Meleti M, Manfredi M, Fornaini C, Nammour S (2015) Tooth extractions in high-risk patients under bisphosphonate therapy and previously affected with osteonecrosis of the jaws: surgical protocol supported by low-level laser therapy. The Journal of craniofacial surgery 26 (3):696-699. doi:10.1097/scs.0000000000001665
191. de Sousa AP, Paraguassu GM, Silveira NT, de SJ, Cangussu MC, Dos Santos JN, Pinheiro AL (2013) Laser and LED phototherapies on angiogenesis. Lasers MedSci 28 (3):981-987. doi:10.1007/s10103-012-1187-z [doi]
192. Smith BG, Lewin JS (2010) Lymphedema management in head and neck cancer. CurrOpinOtolaryngolHead Neck Surg 18 (3):153-158. doi:10.1097/MOO.0b013e32833aac21 [doi];00020840-201006000-00001 [pii]
193. McGarvey AC, Osmotherly PG, Hoffman GR, Chiarelli PE (2014) Lymphoedema following treatment for head and neck cancer: impact on patients, and beliefs of health professionals. European journal of cancer care 23 (3):317-327. doi:10.1111/ecc.12134
194. Deng J, Ridner SH, Dietrich MS, Wells N, Wallston KA, Sinard RJ, Cmelak AJ, Murphy BA (2012) Prevalence of secondary lymphedema in patients with head and neck cancer. JPain SymptomManage 43 (2):244-252. doi:S0885-3924(11)00269-7 [pii];10.1016/j.jpainsymman.2011.03.019 [doi]
195. Deng J, Ridner SH, Dietrich MS, Wells N, Wallston KA, Sinard RJ, Cmelak AJ, Murphy BA (2012) Factors associated with external and internal lymphedema in patients with head-and-neck cancer. IntJRadiatOncolBiolPhys 84 (3):e319-e328. doi:S0360-3016(12)00560-3 [pii];10.1016/j.ijrobp.2012.04.013 [doi]
196. Deng J, Ridner SH, Aulino JM, Murphy BA (2015) Assessment and measurement of head and neck lymphedema: state-of-the-science and future directions. Oral Oncol 51 (5):431-437. doi:10.1016/j.oraloncology.2015.01.005
197. Deng J, Ridner SH, Murphy BA (2011) Lymphedema in patients with head and neck cancer. OncolNursForum 38 (1):E1-E10. doi:U002351J537VXV14 [pii];10.1188/11.ONF.E1-E10 [doi]
198. Lau RW, Cheing GL (2009) Managing postmastectomy lymphedema with low-level laser therapy. PhotomedLaser Surg 27 (5):763-769. doi:10.1089/pho.2008.2330 [doi]
199. Dirican A, Andacoglu O, Johnson R, McGuire K, Mager L, Soran A (2011) The short-term effects of low-level laser therapy in the management of breast-cancer-related lymphedema. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 19 (5):685-690. doi:10.1007/s00520-010-0888-8
200. Omar MT, Shaheen AA, Zafar H (2012) A systematic review of the effect of low-level laser therapy in the management of breast cancer-related lymphedema. SupportCare Cancer 20 (11):2977-2984. doi:10.1007/s00520-012-1546-0 [doi]
201. MT EL, JG EL, de Andrade MF, Bergmann A (2012) Low-level laser therapy in secondary lymphedema after breast cancer: systematic review. Lasers MedSci. doi:10.1007/s10103-012-1240-y [doi]
202. Smoot B, Chiavola-Larson L, Lee J, Manibusan H, Allen DD (2015) Effect of low-level laser therapy on pain and swelling in women with breast cancer-related lymphedema: a systematic review and meta-analysis. Journal of cancer survivorship : research and practice 9 (2):287-304. doi:10.1007/s11764-014-0411-1
203. Wigg J, Lee N (2014) Redefining essential care in lymphoedema. British journal of community nursing Suppl:S20, s22, s24-27
204. Dwivedi RC, Kazi RA, Agrawal N, Nutting CM, Clarke PM, Kerawala CJ, Rhys-Evans PH, Harrington KJ (2009) Evaluation of speech outcomes following treatment of oral and oropharyngeal cancers. Cancer TreatRev 35 (5):417-424. doi:S0305-7372(09)00066-8 [pii];10.1016/j.ctrv.2009.04.013 [doi]
205. Jacobi I, van der Molen L, Huiskens H, van Rossum MA, Hilgers FJ (2010) Voice and speech outcomes of chemoradiation for advanced head and neck cancer: a systematic review. EurArchOtorhinolaryngol 267 (10):1495-1505. doi:10.1007/s00405-010-1316-x [doi]
206. van der Molen L, van Rossum MA, Jacobi I, van Son RJ, Smeele LE, Rasch CR, Hilgers FJ (2012) Pre- and posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: expert listeners’ and patient’s perception. JVoice 26 (5):664-633. doi:S0892-1997(11)00156-1 [pii];10.1016/j.jvoice.2011.08.016 [doi]
207. Meleca RJ, Dworkin JP, Kewson DT, Stachler RJ, Hill SL (2003) Functional outcomes following nonsurgical treatment for advanced-stage laryngeal carcinoma. Laryngoscope 113 (4):720-728. doi:10.1097/00005537-200304000-00025 [doi]
208. Johns MM, Kolachala V, Berg E, Muller S, Creighton FX, Branski RC (2012) Radiation fibrosis of the vocal fold: from man to mouse. Laryngoscope 122 Suppl 5:S107-S125. doi:10.1002/lary.23735 [doi]
209. de Bruijn MJ, ten BL, Kuik DJ, Quene H, Langendijk JA, Leemans CR, Verdonck-de Leeuw IM (2009) Objective acoustic-phonetic speech analysis in patients treated for oral or oropharyngeal cancer. Folia PhoniatrLogop 61 (3):180-187. doi:000219953 [pii];10.1159/000219953 [doi]